Uretron D/s Tablet
NDC Package 12539-144-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Uretron D/s (methenamine, sodium phosphate monobasic, phenyl salicylate, methylene blue, and hyoscyamine sulfate) tablets is uretron D/S tablets are indicated for the treatment of symptoms of irritative voiding. This formulation utilizes a tablet delivery system. Marketed by Doral Pharmamedics Inc Dba A.g. Marin Pharmaceuticals, this product is identified by NDC 12539-144.

Identification & Billing

NDC Package Code
12539-144-01
Package Description
100 TABLET in 1 BOTTLE
Product Code
12539-144
11-Digit Billing Format
12539014401
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
100 EA
RxNorm Crosswalk
  • RxCUI: 1047786 - hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet
  • RxCUI: 1087457 - Uretron D-S 0.12 MG / 81.6 MG / 10.8 MG / 36.2 MG / 40.8 MG Oral Tablet
  • RxCUI: 1087457 - hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet [Uretron DS]
  • RxCUI: 1087457 - Uretron D-S (hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG / sodium phosphate, monobasic 40.8 MG) Oral Tablet

Clinical Specifications

Proprietary Name
Uretron D/s
Non-Proprietary Name
Methenamine, Sodium Phosphate Monobasic, Phenyl Salicylate, Methylene Blue, And Hyoscyamine Sulfate
Substance Name
Hyoscyamine Sulfate; Methenamine; Methylene Blue; Phenyl Salicylate; Sodium Phosphate, Monobasic, Monohydrate
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Uretron D/S tablets are indicated for the treatment of symptoms of irritative voiding. Indicated for the relief of local symptoms, such as inflammation, hypermotility, and pain, which accompany lower urinary tract infections. Indicated for the relief of urinary tract symptoms caused by diagnostic procedures.

Regulatory & Marketing

Labeler Name
Doral Pharmamedics Inc Dba A.g. Marin Pharmaceuticals
Product Type
Human Prescription Drug
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
10-07-2022
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 12539-144-01 identifies a specific commercial package of 100 tablet in 1 bottle of Uretron D/s, a human prescription drug labeled by Doral Pharmamedics Inc Dba A.g. Marin Pharmaceuticals. This product is billed for "EA" each discreet unit and contains an estimated amount of 100 billable units per package. This tablet is formulated for oral use and contains hyoscyamine sulfate; methenamine; methylene blue; phenyl salicylate; sodium phosphate, monobasic, monohydrate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Doral Pharmamedics Inc Dba A.g. Marin Pharmaceuticals on October 07, 2022. The current certification is valid through December 31, 2026.

How is this Doral Pharmamedics Inc Dba A.g. Marin Pharmaceuticals product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 12539014401. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
12539-144-01
11-Digit CMS (5-4-2)
12539-0144-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.